The relationship between platelet, prostaglandins and metastasis of cancer was investigated in 68 cases of primary lung cancer (26 cases with and 42 with out metastasis), 27 cases of benign lung disease, 14 cases of cerebral infarction and 42 helthy controls. The amount of Lipid peroxides in platelet, Thromboxane B
2, 6-keto-prostaglandin F
1α and the rate of Thromboxane B
2/6-keto-prostaglandin F
1α were measured. Three principal results were obtained. First, in the group having primary lung cancer with metastasis, the levels of lipid peroxides in platelet, Thromboxane B
2 and 6-keto prostaglandin F
1α in the serum, as well as the rate of Thromboxane B
2/6-keto prostaglandin F
1α were increased compared to the groups having lung carcinoma without metastasis, benign lung disease and the healthy controls. In addition, the positive rate of lipid peroxides in platelet and Thromboxane B
2 were also increased in this group as compared with the benign lung desease and healthy control groups. (Positive rate of lipid peroxides in platelats and Thromboxane B
2 was 73.1% and 42.3%). Second, the amount of lipid peroxides in platelet showed a positive correlation compared with Thromboxane B
2 (p<0.01, r=0.414), the lipid peroxides in platelet method was considered to be a useful marker as Thromboxane A
2 activity was the same as Thromboxane B
2. The method was also concluded to be useful clinically, because it enabled only a small sample to be examined. Third, maximum platelet aggregation rate of ADP (1×10
-6M, 1×10
-5M), collagen, epinephrine demonstrated no correlation compared with the amount of lipid peroxides in platelet or Thromboxane B
2/6-keto prostaglandin F
1α.
View full abstract